COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies

Ilker Polatoğlu, Tulay Oncu‐Oner, Irem Dalman, Senanur Ozdogan

Open source

DOI
10.1002/mco2.228
Published
2023-04
Container
MedComm
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/mco2.228,
  title = {COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine \& drug development studies},
  author = {Ilker Polatoğlu and Tulay Oncu‐Oner and Irem Dalman and Senanur Ozdogan},
  year = {2023},
  journal = {MedComm},
  doi = {10.1002/mco2.228},
  url = {https://doi.org/10.1002/mco2.228}
}

RIS

TY  - JOUR
TI  - COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
AU  - Ilker Polatoğlu
AU  - Tulay Oncu‐Oner
AU  - Irem Dalman
AU  - Senanur Ozdogan
PY  - 2023
JO  - MedComm
DO  - 10.1002/mco2.228
UR  - https://doi.org/10.1002/mco2.228
ER  - 

APA

Polatoğlu, I., Oncu‐Oner, T., Dalman, I., & Ozdogan, S. (2023). COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies. MedComm. https://doi.org/10.1002/mco2.228

Source records